Champions Oncology
CSBR • NASDAQ
Champions Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert Brainin, with a market cap of $79.7M.
CEORobert Brainin
Next Earnings
No upcoming earnings scheduled for Champions Oncology
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for Champions Oncology
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q3 2026 | $0.04Est: $0.09 | -55.6% | $16.6MEst: $16.6M | -0.3% |  10-Q |
| Dec 15, 2025 | Q2 2026 | $0.06Est: $0.01 | +500.0% | $15.0MEst: $14.0M | +7.1% | 10-Q |
| Sep 15, 2025 | Q1 2026 | $0.02Est: -$0.01 | +300.0% | $14.0MEst: $13.5M | +3.6% | 10-Q |
| Jul 23, 2025 | Q4 2025 | -$0.07Est: -$0.20 | +65.0% | $12.4MEst: $12.0M | +2.8% | 10-K |
| Mar 11, 2025 | Q3 2025 | $0.36Est: $0.30 | +20.0% | $17.0M | — | 10-Q |
| Dec 11, 2024 | Q2 2025 | $0.05Est: $0.01 | +400.0% | $13.5MEst: $13.1M | +3.4% | 10-Q |
| Sep 11, 2024 | Q1 2025 | $0.11Est: -$0.03 | +466.7% | $14.1MEst: $13.2M | +6.3% | 10-Q |
| Jul 18, 2024 | Q4 2024 | $0.01Est: -$0.16 | +106.3% | $14.0MEst: $12.7M | +10.3% | 10-K |
| Mar 12, 2024 | Q3 2024 | -$0.16Est: -$0.15 | -6.7% | $12.0MEst: $13.5M | -10.8% | 10-Q |
| Dec 12, 2023 | Q2 2024 | -$0.15Est: -$0.17 | +11.8% | $11.6MEst: $12.8M | -9.9% | — |
| Sep 13, 2023 | Q1 2024 | -$0.16Est: -$0.10 | -60.0% | $12.6MEst: $13.1M | -3.8% | 10-Q |
| Jul 24, 2023 | Q4 2023 | -$0.17Est: -$0.12 | -41.7% | $13.1MEst: $12.9M | +1.6% | — |